Back to search

Article

Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico Approach

2021-07-22

Abstract excerpt

The existing panels of COVID-19 vaccines are based on the spike protein of earlier SARS-CoV-2 strain that emerged in Wuhan, China. However, the evolving nature of SARS-CoV-2 has resulted in emergence of new variants, thereby, posing a greater challenge in the management of the disease. India faced a deadlier second wave of infections very recently and genomic surveillance revealed that B.1.617 variant and its sub...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
2cf20418-b183-5430-b775-4fe732e48f9a
DOI
10.21203/rs.3.rs-713062/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Impact of B.1.617 and RBD SARS-CoV-2 Variants on Vaccine Efficacy: An In-silico ApproachDOI 10.21203/rs.3.rs-713062/v1
Select a neighboring publication to make it the new centre.